événements, séminaires
23 Septembre 2022 – Sébastian Bouret (ICM, Paris) – Neural basis of decision-making in primates. In the lab and beyond
The presentation will cover the cognitive and neurobiological functions underlying cost-benefits decision making in primates. After covering data from laboratory experiments, I will present recent studies aimed at understanding how these data can help understand how specific neuro-cognitive operations allow… Continue reading
événements, séminaires
16 Septembre, 2022 – Sebastian Jessberger (University of Zurich) – Mechanisms of life-long stem cell activity in the mammalian brain
Neural stem cells generate new neurons throughout life in the mammalian hippocampus. This process, called adult neurogenesis, is critically involved in certain forms of learning and memory. In addition, failing or altered neurogenesis has been associated with a number of… Continue reading
bourses, opportunités
Les lauréats des Bourses de M2 Open Mind 2022
Le Conseil de l’INC a attribué trois bourses de M2 en 2022 à:
Ekaterina Kozlova, dont le projet Modélisation et simulation de la conduction électrique dans des nerfs avec myéline endommagée est supervisé par Samuel Bottani (Equipe Neurophysique MSCmed,… Continue reading
événements, séminaires
24 Juin 2022 – Pierre Paoletti (Institut de Biologie de l’ENS, Paris) – New lights on neurotransmission: from molecular optogenetics to excitatory glycine receptors
The function of the human brain and its remarkable capacity for information storage and experience-dependent change hinge on the dynamics of chemical synapses – main ‘contact points’ between neurons. My team has a long-standing interest in studying the molecular principles… Continue reading
événements, rencontres INC
21 Juin 2022 – Sixième rencontre du Club Autisme, autres troubles du neurodéveloppement et Vision (CAV)
Le thème de cette sixième rencontre du CAV est Variabilités sensorielles dans l’autisme et les TND.
Elle se tiendra le mardi 21 juin 2022 de 14h30 à 16h00 en visioconférence . Le lien zoom pour participer est https://u-paris.zoom.us/j/83362729793?pwd=R2FBWnRyNHB4L0grYWRMbC9YUGpqdz09
Comité d’organisation… Continue reading
événements, séminaires
3 Juin 2022 – David Smith (Cornell University in Ithaca, NY, USA) – The Hippocampus and the Neural Basis of Context-Dependent Memory
The environmental context is known to plays a profound role in memory. The context is a potent retrieval cue that primes the memories that belong to that context. This is highly adaptive because it prevents interference from memories that belong… Continue reading
événements, séminaires
Jeudi, 12 Mai 2022 – Melissa Bowerman (Keele University, UK) – Combining bioinformatic and drug repurposing approaches to develop second-generation therapies for spinal muscular atrophy
Spinal muscular atrophy (SMA) is a devastating childhood disease caused by loss of function of the survival motor neuron (SMN) gene, leading to the death of nerve and muscle cells. The first SMN gene replacement therapies have recently been approved… Continue reading
événements, séminaires
13 Mai 2022 – Alain Chédotal (Institut de la Vision, Paris) – Development and evolution of visual projections
In most animal species including humans, commissural axons connect neurons on the left and right side of the nervous system. This communication between the two sides of the brain and spinal cord is necessary for a series of complex function,… Continue reading
événements, séminaires
22 Avril 2022 – Ariel di Nardo (College de France, Paris) – OTX2 non cell autonomous activity regulates anxiety-like behavior
Our laboratory has been working for several years on the role of non-cell autonomous homeoprotein transcription factors in regulating cerebral cortex physiology. We have shown that in mice the OTX2 homeoprotein is expressed in the choroid plexus, secreted into cerebrospinal… Continue reading
événements, séminaires
1 Avril 2022 – Markus Heilig (Université de Linköping, Suède) – Neurobiological mechanisms of individual vulnerability to alcohol addiction-like behaviors
Neurobiological research on alcohol addiction had grown, but no mechanistically novel medications have been approved in more than 15 years. Promising candidates have failed in development. What have we been missing?
Three themes have emerged from our attempts to address… Continue reading